Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Telomere maintenance by telomerase activation or alternative lengthening of telomeres (ALT) is a major determinant of poor outcome in neuroblastoma. Here, we screen for ALT in primary and relapsed neuroblastomas (n = 760) and characterize its features using multi-omics profiling. ALT-positive tumors are molecularly distinct from other neuroblastoma subtypes and enriched in a population-based clinical sequencing study cohort for relapsed cases. They display reduced ATRX/DAXX complex abundance, due to either ATRX mutations (55%) or low protein expression. The heterochromatic histone mark H3K9me3 recognized by ATRX is enriched at the telomeres of ALT-positive tumors. Notably, we find a high frequency of telomeric repeat loci with a neuroblastoma ALT-specific hotspot on chr1q42.2 and loss of the adjacent chromosomal segment forming a neo-telomere. ALT-positive neuroblastomas proliferate slowly, which is reflected by a protracted clinical course of disease. Nevertheless, children with an ALT-positive neuroblastoma have dismal outcome.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Nature communications - 12(2021), 1 vom: 24. Feb., Seite 1269 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hartlieb, Sabine A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 3.6.4.12 |
|---|
| Anmerkungen: |
Date Completed 03.03.2021 Date Revised 31.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-021-21247-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321859472 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321859472 | ||
| 003 | DE-627 | ||
| 005 | 20240331232554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-021-21247-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1358.xml |
| 035 | |a (DE-627)NLM321859472 | ||
| 035 | |a (NLM)33627664 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hartlieb, Sabine A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.03.2021 | ||
| 500 | |a Date Revised 31.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Telomere maintenance by telomerase activation or alternative lengthening of telomeres (ALT) is a major determinant of poor outcome in neuroblastoma. Here, we screen for ALT in primary and relapsed neuroblastomas (n = 760) and characterize its features using multi-omics profiling. ALT-positive tumors are molecularly distinct from other neuroblastoma subtypes and enriched in a population-based clinical sequencing study cohort for relapsed cases. They display reduced ATRX/DAXX complex abundance, due to either ATRX mutations (55%) or low protein expression. The heterochromatic histone mark H3K9me3 recognized by ATRX is enriched at the telomeres of ALT-positive tumors. Notably, we find a high frequency of telomeric repeat loci with a neuroblastoma ALT-specific hotspot on chr1q42.2 and loss of the adjacent chromosomal segment forming a neo-telomere. ALT-positive neuroblastomas proliferate slowly, which is reflected by a protracted clinical course of disease. Nevertheless, children with an ALT-positive neuroblastoma have dismal outcome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Proteome |2 NLM | |
| 650 | 7 | |a X-linked Nuclear Protein |2 NLM | |
| 650 | 7 | |a EC 3.6.4.12 |2 NLM | |
| 700 | 1 | |a Sieverling, Lina |e verfasserin |4 aut | |
| 700 | 1 | |a Nadler-Holly, Michal |e verfasserin |4 aut | |
| 700 | 1 | |a Ziehm, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Toprak, Umut H |e verfasserin |4 aut | |
| 700 | 1 | |a Herrmann, Carl |e verfasserin |4 aut | |
| 700 | 1 | |a Ishaque, Naveed |e verfasserin |4 aut | |
| 700 | 1 | |a Okonechnikov, Konstantin |e verfasserin |4 aut | |
| 700 | 1 | |a Gartlgruber, Moritz |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Young-Gyu |e verfasserin |4 aut | |
| 700 | 1 | |a Wecht, Elisa Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Savelyeva, Larissa |e verfasserin |4 aut | |
| 700 | 1 | |a Henrich, Kai-Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Rosswog, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Fischer, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Hero, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, David T W |e verfasserin |4 aut | |
| 700 | 1 | |a Pfaff, Elke |e verfasserin |4 aut | |
| 700 | 1 | |a Witt, Olaf |e verfasserin |4 aut | |
| 700 | 1 | |a Pfister, Stefan M |e verfasserin |4 aut | |
| 700 | 1 | |a Volckmann, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Koster, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Kiesel, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Rippe, Karsten |e verfasserin |4 aut | |
| 700 | 1 | |a Taschner-Mandl, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Ambros, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Brors, Benedikt |e verfasserin |4 aut | |
| 700 | 1 | |a Selbach, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Feuerbach, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Westermann, Frank |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 12(2021), 1 vom: 24. Feb., Seite 1269 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g number:1 |g day:24 |g month:02 |g pages:1269 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-021-21247-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |e 1 |b 24 |c 02 |h 1269 | ||